I’ve recently been notified that the CeliAction Study is continuing to recruit subjects with celiac disease. ALV003 (an enzyme) is being investigated as a treatment to augment the gluten-free diet by providing protection from gluten cross-contamination. It is also being researched as a treatment for nonresponsive celiac disease. All questions about this post will be answered by a CeliAction Study representative. I just returned to “real life” after running the NYC marathon for Team Gluten-Free and I look forward to sharing my experience with all of you soon in a separate post. Thank you for reading! -Jess
National study to help advance celiac disease research
The CeliAction Study is a clinical research study designed to evaluate an investigational drug for celiac disease. The study will explore whether the investigational drug is able to improve the damage in the lining of the intestine caused by ingesting even small traces of gluten. The study will also evaluate whether the investigational drug improves any symptoms of celiac disease.
You may qualify for the CeliAction Study if you:
- Have been diagnosed with celiac disease by a healthcare professional
- Are attempting to be on a gluten-free diet
- Have experienced at least one moderate or severe symptom of celiac disease in the past month
There are other criteria that you must meet to qualify for participation. The study staff will explain the requirements to you and answer any of your questions.
As a volunteer in a clinical trial, you may:
- Participate in a research process that may lead to new treatment options
- Learn new information about your health
- Receive study-related care from qualified physicians
To learn more about this research study, visit www.CeliActionStudy.com or call 1-855-3333-ACT.